Search company, investor...
Hennepin Healthcare Research Institute company logo

Hennepin Healthcare Research Institute

hhrinstitute.org

About Hennepin Healthcare Research Institute

Hennepin Healthcare Research Institute is a medical research nonprofit organization that works to improve patient care and the health of its community through research and education. It is based Minneapolis, Minnesota.

Headquarters Location

701 Park Ave Suite PP7.700

Minneapolis, Minnesota, 55415,

United States

Loading...

Loading...

Hennepin Healthcare Research Institute Patents

Hennepin Healthcare Research Institute has filed 4 patents.

The 3 most popular patent topics include:

  • analgesics
  • cigarette brands
  • morphinans
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/14/2018

9/13/2022

Stimulants, Smoking, Smoking cessation, Nicotinic agonists, Cigarette brands

Grant

Application Date

8/14/2018

Grant Date

9/13/2022

Title

Related Topics

Stimulants, Smoking, Smoking cessation, Nicotinic agonists, Cigarette brands

Status

Grant

Latest Hennepin Healthcare Research Institute News

Researchers adapt health system COVID-19 collaboration to track near-real-time trends in visits for substance use

Nov 10, 2023

Detailed, timely data will inform equity-driven approaches to the drug overdose epidemic Hennepin Healthcare Research Institute Minneapolis, Minn. – In a recently released study, researchers at Hennepin Healthcare and other Minnesota health systems describe how a COVID-19 collaboration across Minnesota health systems was adapted to monitor near-real-time trends in substance use–related hospital and emergency department (ED) visits. The Minnesota Electronic Health Record Consortium (MNEHRC), developed in response to the COVID-19 pandemic, repurposed its surveillance methods to identify health disparities and inform equity-driven approaches to the overdose epidemic. MNEHRC’s study, "Minnesota Data Sharing May Be Model for Near-Real-Time Tracking of Drug Overdose Hospital and ED Trends," was published in the November issue of Health Affairs, the leading health policy journal in the United States. Using data from all six adult hospitals and EDs in Hennepin County, Minnesota, researchers found large increases in methamphetamine- and opioid-involved hospital and ED visits. Throughout the study period, Native American, Black, and multiple-race people experienced the highest rates of drug-involved hospital and ED visits. “This study sets the framework for the data needed to reduce overdose deaths in Hennepin County,” explains Dr. Tyler Winkelman, who led the project and is past-president of the MNEHRC. “We spent a great deal of time building the infrastructure of the Consortium to address and inform the impact of COVID-19. We repurposed the collaboration and tools we developed to learn more about substance use trends in near real-time to inform interventions and, ultimately, save lives.” The use of EHR data allows for detailed monitoring of the impact of the drug overdose epidemic across racial and ethnic groups. Additionally, monitoring drug-involved health care use through EHR data has the potential to help public health officials identify trends in near real time before deaths increase and may also inform early intervention and policy decisions. Learn more “Minnesota Data Sharing May Be Model for Near-Real-Time Tracking of Drug Overdose Hospital and ED Trends” article, HealthAffairs:   https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2023.00281

Hennepin Healthcare Research Institute Frequently Asked Questions (FAQ)

  • Where is Hennepin Healthcare Research Institute's headquarters?

    Hennepin Healthcare Research Institute's headquarters is located at 701 Park Ave, Minneapolis.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.